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Mammary epithelial stem cells are vital to tissue
expansion and remodeling during various phases of
postnatal mammary development. Basal mammary
epithelial cells are enriched in Wnt-responsive cells
and can reconstitute cleared mammary fat pads
upon transplantation into mice. Lgr5 is a Wnt-regu-
lated target gene and was identified as a major
stem cell marker in the small intestine, colon,
stomach, and hair follicle, as well as in kidney neph-
rons. Here, we demonstrate the outstanding regener-
ative potential of a rare population of Lgr5-express-
ing (Lgr5+) mammary epithelial cells (MECs). We
found that Lgr5+ cells reside within the basal popula-
tion, are superior to other basal cells in regenerating
functional mammary glands (MGs), are exceptionally
efficient in reconstituting MGs from single cells, and
exhibit regenerative capacity in serial transplanta-
tions. Loss-of-function and depletion experiments
of Lgr5+ cells from transplanted MECs or from
pubertal MGs revealed that these cells are not only
sufficient but also necessary for postnatal mammary
organogenesis.INTRODUCTION
Adult stem cells are characterized by their ability to both self-
renew and to differentiate into specialized cells. Unraveling the
hierarchy of mammary stem and progenitor cells has been of
great interest because the mammary gland (MG) undergoes
extensive tissue expansion and remodeling at various phases
throughout adult life. Moreover, deciphering the stem cell
players contributing to normal mammary development is key
to understanding subsequent pathologies, such as cancer
transformation. During pubertal development, which happens
between 3 and 8 weeks of age in mice, the mammary epithelium
undergoes glandular expansion. This yields a branching network
of ducts composed of two primary epithelial cell lineages: myoe-70 Cell Reports 3, 70–78, January 31, 2013 ª2013 The Authorspithelial/basal, and luminal. During pregnancy, the epithelium
goes through additional lobuloalveolar differentiation to allow
lactation (Deome et al., 1959; Shackleton et al., 2006; Stingl
and Caldas, 2007; Stingl et al., 2006; Visvader and Lindeman,
2006; Welm et al., 2003; Woodward et al., 2005). The MG can
be regenerated efficiently by transplanting mammary epithelial
cells (MECs) into cleared mammary fat pads. Serial transplan-
tation and limiting dilution assays of primary cultures derived
from clonal outgrowths have pointed to the existence of a rare
subset of mammary cells that function as stem cells and recon-
stitute functional MGs (Kordon and Smith, 1998). This basal pop-
ulation, which includes mammary stem cells, is characterized by
the surface antigen profile LinCD24+CD29high or LinCD24low
CD49fhigh (Shackleton et al., 2006; Stingl et al., 2006) and is
enriched in Wnt-responsive cells (Zeng and Nusse, 2010).
Wnt signaling has been implicated in different stages of mam-
mary development as well as in mammary oncogenesis (Boras-
Granic et al., 2006; Brisken et al., 2000; Chu et al., 2004; Lindvall
et al., 2006, 2009; Nusse and Varmus, 1982; Roelink et al., 1990).
The Wnt coreceptor Lrp5 has been described as a marker of
mammary stem cells (Badders et al., 2009), and secreted Wnt
proteins are proposed as important self-renewal factors for
MG stem cells (Zeng and Nusse, 2010). Lgr5, a downstream
target of Wnt, was identified as a marker of adult stem cell
populations in the small intestine, colon (Barker et al., 2007),
stomach (Barker et al., 2010), and hair follicle (Barker et al.,
2008), organs that undergo extensive postnatal regenera-
tion. Recently, lineage-tracing experiments revealed that Lgr5+
stem/progenitor cells also contribute to nephron formation
during kidney development (Barker et al., 2012). Here, we
unmask the regenerative potential of a rare Lgr5-expressing
(Lgr5+) mammary cell population and its indispensable contribu-
tion to pubertal mammary development.RESULTS
Lgr5Expression Is Restricted to aRare Subpopulation of
Cytokeratin 14+, LinCD24+CD49fhigh Basal Cells
To identify cells that express Lgr5 in the MG, we used the Lgr5
knockin mouse model in which EGFP reporter gene expression
is driven by the endogenous Lgr5 regulatory sequences (Barker
Figure 1. Lgr5 Expression Is Restricted to a Rare Subpopulation of Cytokeratin 14+, LinCD24+CD49fhigh Mammary Basal Cells
(A) The expression of Lgr5was examined in cryosections from 7-week-old Lgr5-EGFP MGs with an anti-GFP antibody (green). Carmine stain of a representative
MGwhole mount demonstrates that Lgr5+ ducts are located to the nipple area, but not to the invading front. Around the lymph node (LN), there are some positive
and negative ducts.
(B) Cryosections costained with anti-GFP and anti-K14. Lgr5+ cells (green) are located to the suprabasal layer of the ducts and are a subpopulation of the
myoepithelial K14+ cells (red).
(C) MGs were isolated from Lgr5-EGFPmice and analyzed by flow cytometry for the expression of the cell surface markers Ter119, CD45, CD31 (Lin), CD24, and
CD49f. Lgr5+ cells (GFP+) were part of the LinCD24+CD49fhigh cells (stem cell-enriched population). Lgr5+ cells are 0.3% of total mammary cells and 2.5% of
LinCD24+CD49fhighbasal cells. GFP+ cells within the luminal population are 0.009% of total.
(D) Summary of flow cytometry data in Figure 1C, Lgr5+ cells in 7.5-week-old pubertal female mice, percentage (%) of Lgr5+ cells of total (n = 14), and of
LinCD24+CD49fhighbasal cells (n = 7). See also Figure S1.
(E) Real-time, quantitative PCR analysis of the Lgr5+ cell population (relative to Lgr5mammary cells) revealed that they are high for basal but not luminal markers.
PR, progesterone receptor; ERa, estrogen receptor a. See also Table S1.
Bars represent SE.et al., 2007). In adult pubertal MGs, only 14% (±2% SE) of ducts
had Lgr5+ cells, and they were all localized to the nipple side
(taking the lymph node as a point of reference), as previously
illustrated by Van Keymeulen et al. (2011). The nipple is where
the fetal epidermis initially invaginates into the mammary fat
pad and is the origin growth point of the mammary epithelium
(Figure 1A). Lgr5+ cells were a subset of cytokeratin 14-positive
(K14+) cells and were localized to the suprabasal position (Fig-
ure 1B), similar to that previously described for mammary stem
cells by Sleeman et al. (2007). In MGs, adult stem cells have
been defined by flow cytometry as a rare subset of LinCD24+
CD29high (Shackleton et al., 2006) or LinCD24lowCD49fhigh
basal cells (Stingl et al., 2006), and a subpopulation of such cells
exhibits the capacity to regenerate an entire MG in vivo. The vast
majority of Lgr5+ cells were basal, LinCD24+CD49fhigh (Fig-
ure 1C and Figure S1) and were quite rare, comprising 0.26%
(one Lgr5+ cell per 386 cells) of total dissociated cells in pubertal
MGs (Figure 1D). Previous studies have estimated the frequency
of mammary stem cells or mammary repopulating units (MRUs)
from adult virgin mouse MG to be 1 per 1,400 dissociated cells(for FVB background; Stingl et al., 2006); in contrast, 3%–7%
of cells in intestinal crypts express Lgr5 (Barker et al., 2007). In
pubertal glands, among the mammary basal cells, only 6%
were Lgr5+ (Figure 1D); this was corroborated by the expression
profile of Lgr5+ cells, which showed high levels of basal but low
levels of luminal epithelial markers (Figure 1E).
Within the LinCD24+CD49fhigh Basal Population, Lgr5+
Cells Are Highly Potent in Generating Functional
Mammary Outgrowths
The analysis described above revealed that Lgr5+ cells are a
subset of the LinCD24+CD49fhigh basal cells previously re-
ported to include stem cells (Shackleton et al., 2006). To assess
MG reconstitution competence, we challenged the Lgr5+ cells
for mammary regeneration and compared them to Lgr5-negative
(Lgr5) basal cells in limiting dilution experiments (Figure 2A). In
these experiments, we transplanted 10, 50, and 100 Lgr5+
versus Lgr5 basal cells into cleared fat pads. The number of
cells transplanted was chosen on the lower range to increase
the stringency of the assay, focus on a small subset of basalCell Reports 3, 70–78, January 31, 2013 ª2013 The Authors 71
Figure 2. Within the LinCD24+CD49fhigh Basal Population, Lgr5+
Cells Are Highly Potent in Generating Functional Mammary
Outgrowths
(A) Lgr5+ (GFP+) and nonexpressing (GFP) cells from Lgr5-EGFP were iso-
lated by flow cytometry from the LinCD24+CD49fhigh basal population and
injected (10, 50, or 100 cells) into clearedmammary fat pads. Outgrowths were
analyzed 6 weeks posttransplantation.
(B) Transplanted basal Lgr5+ cells have higher numbers of outgrowths
compared to the basal Lgr5 cells. Data are pooled from three different
experiments.
(C) Whole-mount carmine-stained representative outgrowths show that ten
basal Lgr5+ cells are able to reconstitute a full MG versus no outgrowth for
basal Lgr5-transplanted cells.
(D) Mice transplanted with ten Lgr5+ cells were mated with males, and their
MGs were analyzed on day 18.5 (E18.5) of pregnancy.
(E) Whole-mount carmine-stained mammary epithelial outgrowths from E18.5
pregnant female mice transplanted with ten basal Lgr5+ cells that under-
went full lobuloalveolar differentiation (basal Lgr5+), comparable to the en-
dogenous epithelium in MG #3 of the recipient mouse (upper panels). MG
72 Cell Reports 3, 70–78, January 31, 2013 ª2013 The Authorscells, and avoid false negatives owing to Lgr5+ cells that express
low levels of GFP and could therefore be sorted into the Lgr5
group. We found that within the basal population, Lgr5+ cells
generated MGs far more efficiently than did basal Lgr5 cells.
On average, 27% (±5% SE) of Lgr5+ cells were able to regen-
erate a full MG, within the 10–100 cell range, or 1 MRU per 3.7
Lgr5+ cells (Figures 2B and 2C). We then tested functionality
upon pregnancy (Figure 2D) and found that these outgrowths
were able to undergo full lactational lobuloalveolar differentiation
and express the milk protein, b-casein (Figure 2E). Characteriza-
tion of single basal Lgr5+ cells versus basal Lgr5 cells revealed
that the different functional mammary reconstitution abilities of
the two subsets are based on differences in gene expression
of lineage differentiation, stem cell, and pluripotency markers,
demonstrating that these populations are distinct (Figure S2).
Lgr5+ Cells Can Regenerate a MG from a Single Cell and
Maintain a Regenerative Potential through Serial
Transplantations
Because Lgr5+ cells within the basal cell population were highly
efficient in regenerating a full MG in limiting dilution experiments,
we tested them for classical stem cell characteristics of multipo-
tency and self-renewal. First, we assessed their ability to regen-
erate fully differentiated MGs from single cells (Figure 3A). We
observed that 13 outgrowths were generated from 54 single
Lgr5+ transplanted cells (Figure 3B), demonstrating that 24%
of Lgr5+ single cells were able to regenerate a full MG equivalent
to 1 MRU per 4.2 Lgr5+ cells. These results are similar to those
of the limiting dilution experiments (Figure 2). On close examina-
tion, we observed substantial epithelial outgrowth in the mam-
mary fat pads (Figures 3C and S3) and demonstrated that these
single transplanted Lgr5+ cells were multipotent because they
were able to differentiate into both mammary epithelial lineages
(myoepithelial/basal K14+ and luminal K8+ cells) (Figure 3D). In
addition, when we serially transplanted epithelial outgrowths
from primary transplants of Lgr5+ cells (Figure 3E), the Lgr5+ out-
growths retained their regenerative potential through secondary
and tertiary transplants, demonstrating a long-term, regenera-
tive potential (Figures 3F and 3G).
Depletion Experiments Demonstrate that Lgr5+ Cells
Are Necessary for Postnatal MG Organogenesis
To determine whether Lgr5+ cells are not only sufficient but also
necessary for postnatal MG organogenesis, we used the Lgr5-
DTR:GFP mice to deplete Lgr5+ cells following administration
of diphtheria toxin (DTx) (Figure 4A). This mouse model was
used previously to demonstrate the dispensability of intestinal
Lgr5+ cells under steady-state conditions (Tian et al., 2011).
However, depletion of Lgr5+ cells from transplanted MECs im-
mediately posttransplantation impaired the outgrowth of Lgr5-
DTR:GFP donor epithelium, compared to the contralateral MG
transplanted withWTMECs (Figure 4B). As an additional control,
we found that the majority of MECs from Lgr5-DTR:GFP and WT
mice not treated with DTx (i.e., in the presence of Lgr5+ cells)sections from the same mice stained positive for the milk protein, b-casein
(lower panels; brown).
See also Figure S2 and Table S2.
Figure 3. Lgr5+ Cells Can Regenerate a MG from a Single Cell and Maintain Regenerative Potential through Serial Transplantations
(A) Single mammary Lgr5+ (GFP+) cells from Lgr5-EGFP crossed into the LifeAct-RFP mice were isolated by flow cytometry into 96-well plates and transplanted
into cleared mammary fat pads. Outgrowths were analyzed at 8 weeks posttransplantation.
(B) From transplants of single adult mammary Lgr5+ cells in 54 MGs, 13 mammary outgrowths were observed.
(C) A representative RFP+mammary outgrowth from a single Lgr5+ cell, exhibiting a full epithelial tree (left) with ductal structures at higher magnification of boxed
area (right).
(D) Outgrowths from single Lgr5+ cells differentiate into the myoepithelial (K14+ in red) and luminal (K8+ in green) lineages (left). Boxed area magnified (right). See
also Figure S3.
(E) Mammary outgrowths from two mice transplanted with 100 Lgr5+ cells (isolated from Lgr5-EGFP crossed into the LifeAct-RFP mice) were collected and
retransplanted into ten mice each for secondary and the same for tertiary outgrowths.
(F and G) Lgr5+ outgrowths retain their regenerative potential through secondary (F) and tertiary (G) transplants. RFP images are representative of the mammary
outgrowths.were able to reconstitute mammary outgrowth (Figure 4C). Un-
cleared, endogenous mammary tissue from the WT recipient
mice was not affected by DTx administration (Figure S4B). The
total outgrowth area for Lgr5-DTR:GFP epithelial transplants
(including impaired ducts, as shown in Figure S4A) was also
significantly reduced in DTx-treated mice relative to the contra-
lateral WT transplants (Figure 4D). These experiments indicate
that, although all other epithelial cells were not depleted, the
absence of Lgr5+ cells was detrimental to adequate MG recon-
stitution. This protocol allowed targeted MG Lgr5+ cell depletion
because the recipient mice do not carry the Lgr5-DTR:GFP
transgene. Mammosphere-forming assays in culture confirmed
the indispensability of Lgr5+ cells (Figure S4C).
To complement the results above, we examined the role of
Lgr5+ cells in postnatal MG organogenesis, in a more physiolog-ical setting, by injecting DTx to pubertal mice that were either
Lgr5-DTR:GFP or WT littermates (Figure 5). Depletion of Lgr5+
cells during pubertal MG development resulted in impaired
ductal invasion (Figures 5A and 5B) and, interestingly, also in
a significant reduction in the number of terminal end buds
(TEBs) at the epithelial invading front (Figures 5C and 5D),
even though Lgr5+ cells (Figure 1A) and their lineage-specific
progeny (Figures 5E and S5) are absent from the TEBs. In
this context, although Lgr4 has been shown to play a minor
role in MG development (Oyama et al., 2011), Lgr4+ cells were
not interchangeable with Lgr5+ cells because a significant
phenotype was observed upon Lgr5+ cell depletion. These
data show that under normal physiology, although all other
cells (including additional progenitor cells) were not depleted,
the presence of Lgr5+ cells is necessary for MG pubertalCell Reports 3, 70–78, January 31, 2013 ª2013 The Authors 73
Figure 4. Depletion Experiments Demonstrate that Lgr5+ Cells Are Necessary for MG Epithelial Reconstitution
(A) Depletion of Lgr5+ cells was achieved utilizing Lgr5-DTR:GFP crossed into actin-RFPmice, injected with 50 ng/g BWDTx, analyzed 24 hr post-DTx i.p. (Lgr5+
cells are 0.1% of total dissociated mammary cells versus 0% in DTx-injected mice).
(B) Isolated primary MECs of Lgr5-DTR:GFP mice or WT littermates transplanted into contralateral precleared mammary fat pads with or without DTx admin-
istration. MGs collected 3 weeks posttransplantation had significantly impaired outgrowths in the Lgr5-DTR:GFP transplants versus the WT controls.
(C) To assess the growth potential of the Lgr5-DTR:GFP and control littermate, mice transplanted with the same cells as in (B) but not treated with DTx reveal no
difference between the two contralateral sides.
(D) Outgrowth area for Lgr5-DTR:GFP epithelial transplants (including impaired ducts) relative to the contralateral WT transplants is significantly reduced in
DTx-treated mice (*p = 0.006). Bars represent SE.
See also Figure S4.development and reinforce the depletion results in the trans-
plantation setting.
DISCUSSION
Classically, stem cells are characterized by their ability to self-
renew as well as to differentiate into specialized cells. According
to these criteria, Lgr5+ cells have been identified as adult stem
cells in the small intestine, colon (Barker et al., 2007), stomach
(Barker et al., 2010), and hair follicle (Barker et al., 2008). Our
study now shows that Lgr5+ cells are also adult stem cells
in the MG. By transplantation assays, we demonstrated that74 Cell Reports 3, 70–78, January 31, 2013 ª2013 The Authorsmost Lgr5+ cells are a subset of the basal population previously
shown to include the mammary stem cells, exhibiting superior
reconstitution capabilities as compared to other cells within
that population and are also extremely efficient in regenerating
a MG from a single cell. The reconstituted MG epithelial tree
was also functional because it was able to undergo adequate
differentiation during pregnancy and produce a milk protein.
Lgr5+ cells were multipotent and maintain regenerative potential
in serial transplantations and, therefore, sufficient for postnatal
MG organogenesis. They were also necessary for MG organo-
genesis as shown in depletion assays in both transplantation
and physiological settings.
Figure 5. Depletion of Lgr5+ Cells during
Pubertal Development Results in Impaired
Ductal Invasion and TEB Formation
(A) Carmine-stained MG of 4.5-week-old Lgr5-
DTR:GFP mice (n = 6) or WT littermates (n = 4) that
were i.p. injected with DTx demonstrates sig-
nificantly reduced ductal invasion in the Lgr5-
DTR:GFP mice.
(B) Quantification of data presented in (A).
*p = 0.004.
(C) Depletion of Lgr5+ cells from Lgr5-DTR:GFP
mice resulted in significant reduction in the
number of TEBs per MG versus WT littermates.
Arrows indicate the TEBs.
(D) Quantification of data presented in (C).
*p = 0.0015.
(E) Whole mounts of 5-week-old Lgr5-EGFP-
IRES-creERT2/Rosa-Tomato mice 1 week past
start of Tamoxifen (TAM) induction indicated that
Lgr5+ cell progeny is close to the nipple area (left)
and, according to its localization and shape, mark
myoepithelial cells (middle, enlargement of red
boxed area in left) and not TEBs in the invading
front (carmine-stained tissue on right).
Bars represent SE. See also Figure S5.The frequency of MRUs was previously estimated to be
between 1 MRU per 8–17 cells using transplants of single cells
or 1 per 64 cells within the LinCD24+CD29high population of
mammary cells (Shackleton et al., 2006) or 1 per 60 cells (for
FVB background) and 1 per 90 cells (for C57BL/6 background)
within the LinCD24+CD49fhigh cells (Stingl et al., 2006) in limiting
dilution experiments. More recently, the stem cell frequency
within the adult LinCD24+CD49fhigh population was estimated
as 1 per 50 cells when coinjected with Matrigel (Spike et al.,
2012). The reconstitution capabilities of one per four cells that
we observed are remarkable, bringing us closer to obtaining
a homogeneous population of MRUs.
Although previous transplant experiments suggested a com-
mon progenitor for both major mammary epithelial lineages
(myoepithelial/basal and luminal) (Shackleton et al., 2006; Stingl
et al., 2006), a recent study that utilized lineage-tracing assays
pointed to two different progenitors for these lineages as early
as birth (Van Keymeulen et al., 2011) and, therefore, suggested
a more restricted fate for the Lgr5+cells, which was reinforced
in a recent study by de Visser et al. (2012) and also in our study.
These data point to important differences between lineage-
tracing and transplantation techniques. Indeed, individual stem
cells can have different roles under physiological, homeostatic
conditions visualized by lineage tracing (van Amerongen et al.,
2012), compared to when they are challenged to regenerate an
entire organ in the transplant assays (Keller et al., 2011). Thus,Cell Reports 3, 70–7lineage-tracing experiments using an
Lgr5-CreER line show that Lgr5+ cells
give rise only to myoepithelial cells in
pubertal MGs (Van Keymeulen et al.,
2011), whereas our transplant experi-
ments demonstrated that a single Lgr5+
cell is sufficient to regenerate a completemammary epithelium and differentiates into both myoepithelial
and luminal cells. The transplant assays might therefore uncover
a regenerative potential of Lgr5+ cells that would be inhibited
during MG pubertal development. However, in all the previous
studies, depletion of a specific cell population in the presence
of all the other cells was not attempted. We now have demon-
strated that, in the MG, the unique approach of specific Lgr5+
cell depletion resulted in significantly impaired organogenesis,
indicating that Lgr5+ cells are required during both regeneration
from transplanted MECs but also, and more importantly, during
physiological pubertal development.
Previous studies indicate that mammary stem cells are likely to
be present in any portion of the epithelial branches (Kordon and
Smith, 1998). Our study showed that Lgr5+ cells, although able to
regenerate a full MG, are clustered toward the nipple area in
pubertal MGs, where the branching of the epithelium originates,
and they or their progeny is not found at the invading front of the
ductal tree. However, Lgr5+ cell depletion in the transplants re-
sulted in significantly impaired reconstitution, although all other
epithelial cells were not targeted for depletion. Moreover, Lgr5+
cell depletion during physiological MG organogenesis also
resulted in impaired ductal invasion and specifically was charac-
terized by diminished TEBs. TEBs are essential to pubertal
MG development and contain additional progenitor populations
(as Axin 2+ cells; van Amerongen et al., 2012). Our data indi-
cate that even if there are additional stem/progenitor cells that8, January 31, 2013 ª2013 The Authors 75
contribute to MG organogenesis, Lgr5+ cells are not only suffi-
cient but also essential for this process and suggest a cross-
talk between various stem/progenitor cells during normal MG
development.
Stem cells are key for understanding both normal develop-
ment as well as associated pathologies. In fact, Lgr5 was first
described as a gene expressed in colon cancer cells (van de
Wetering et al., 2002). Moreover, it has since been postulated
that transformation of Lgr5+ stem cells drivesmalignant progres-
sion in the small intestine and colon (Barker et al., 2009), and
stem cell activity has been demonstrated in Lgr5+ cells in mouse
intestinal adenoma (Schepers et al., 2012). Lgr5 is also overex-
pressed in other cancers (McClanahan et al., 2006; Oskarsson
et al., 2011; Yamamoto et al., 2003), including breast cancer
(Oskarsson et al., 2011). The fact that Lgr5+ cells are particularly
efficient in regenerating a full MG suggests that they could also
effectively play an active role in breast cancer once they are
transformed. Because Wnt signaling has been implicated in
different stages of mammary oncogenesis, future studies should
explore the role of Lgr5+ cells as breast cancer stem cells. More-
over, R-spondins were recently shown to potentiate Wnt/b-cat-
enin signaling through Lgr5 (Carmon et al., 2011; de Lau et al.,
2011; Gong et al., 2012). Because local epithelial R-spondin 1
signaling is required for normal development of the MG (Chadi
et al., 2009), future studies evaluating the role of Lgr5 as a re-
ceptor for R-spondin during mammary development and cancer
are worth pursuing.
EXPERIMENTAL PROCEDURES
Mouse Strains
C57BL/6J (Jackson Laboratories), b-actin-RFP (Long et al., 2005), LifeAct-
RFP (Riedl et al., 2010), Lgr5-EGFP-IRES-creERT2 (Lgr5-EGFP) (Barker
et al., 2007), Lgr5-DTR:GFP (Tian et al., 2011), and Ai14 Rosa-Tomato (Madi-
sen et al., 2010) mice were bred and maintained in the UCSF animal facility
according to IACUC guidelines. All mice were maintained in C57BL6J back-
ground. b-Actin-RFP and LifeAct-RFP reporter mice were used interchange-
ably to specifically identify and visualize mammary outgrowths from the
donor mice.
Mammary Cell Preparations
MGs were dissected from pubertal (7- to 9-week-old) female mice. For flow
cytometry and limiting dilution experiments, after mechanical dissociation
with a scalpel, the tissue was placed in culture medium (DMEM/F12 with
5 ng/ml insulin and 50 ng/ml gentamycin (UCSF Cell Culture Facility) contain-
ing 2 mg/ml collagenase-1 (Sigma-Aldrich), and digested for 30 min at 37C.
The resulting suspension was sequentially resuspended in 2 U/ml DNase for
3 min at room temperature (RT), washed and dissociated with 2 ml 0.05%
trypsin/EDTA (UCSF Cell Culture Facility) for 10 min at 37C, and filtered
through a 70 mm filter. Erythrocytes were lysed with Red Blood Cell Lysis
Buffer (protocol ID PS00000002; Gilman et al., 2002) for 1 min at RT. For the
DTx depletion experiments, epithelium-enriched organoids were prepared
as described previously by Ewald et al. (2008), then dissociated with 2 ml
0.05% trypsin/EDTA and filtered as described above.
Cell Labeling, Flow Cytometry, and Sorting
Antibodies against the mouse antigens CD45, CD31, TER119, CD49f, and
CD24 were purchased from eBioscience. For the single-cell transplants,
single Lgr5-GFP+ cells were sorted into 96-well plates in minimal medium
plus 2.5 nM FGF2 (Ewald et al., 2008). Flow cytometry was performed with
the use of LSRII for data analysis and FACS ARIA for cell sorting (BD
Biosciences).76 Cell Reports 3, 70–78, January 31, 2013 ª2013 The AuthorsMammary Fat Pad Transplantation
Cleared fat pads from 3-week-old female nude mice (Simenson) were trans-
planted with 1–100 MECs in 50/50 Matrigel/minimal medium plus 2.5 nM
FGF2 (Ewald et al., 2008). The tissues cleared from the MGs were carmine
stained as described below to validate adequate clearing of the native epithe-
lium (to ensure that the native epithelium had not yet reached the lymph
node). The transplanted mammary epithelium was allowed to grow from 3
to 8 weeks, and mammary outgrowths were analyzed by whole-mount stain-
ing with carmine, whole-mount fluorescence, or flow cytometry. For the
secondary and tertiary transplants, pieces of mammary fat pad containing
epithelium were transplanted into cleared fat pads from 3-week-old female
nude mice. Mammary outgrowths were analyzed 5 weeks after transplants.
Outgrowths were considered positive when the epithelium invaded at least
half of the fat pad. For single-cell transplants and serial transplantation exper-
iments, Lgr5-EGFP-IRES-creERT2 mice were crossed into the LifeAct-RFP
reporter mice, and for Lgr5 depletion experiments, Lgr5-DTR:GFP mice
were crossed into the b-actin-RFP reporter mice to allow easier and reliable
detection of outgrowths.
Histochemistry, Immunohistochemistry, and Immunofluorescence
Mammary whole mounts were stained with carmine Alum (Sigma-Aldrich).
Cryo- or paraffin sections from the inguinal (#4) MGs of Lgr5-EGFP mice or
from mammary outgrowths were labeled using the following primary anti-
bodies: GFP (Abcam; ab5450, 1:200); cytokeratin 14 (Covance; PRB-155P,
1:500); cytokeratin 8 (Troma 1, Developmental Studies Hybridoma Bank,
Iowa; 1:50); and b-casein (ABBIOTEC; #250558, 1:200).
Real-Time PCR
Sorted cell populations were lysed, and RNA was extracted using a QIAGEN
mini kit (74104). cDNA synthesis was performed using the Invitrogen Super-
Script III system (18080-051), and quantitative reverse-transcription PCR
was done via the SYBR Green (Applied Biosystems; 4309155) method and
an Eppendorf Realplex Mastercycler. Primer sequences are listed in Table
S1. Primers were purchased from SABiosciences. Relative quantification of
gene expression was calculated according the Pfaffl method. Target gene
expression in each cell subpopulation was normalized to HPRT and GAPDH
reference gene expression. The data reported are one representative ex-
periment of three independent sorting and quantitative reverse-transcription
PCR experiments.
DTx-Mediated Cell Depletion
Mammary fat pads from 3-week-old female nude mice (Simenson) were
cleared to remove all endogenous epithelium, and the recipient mice were
allowed to grow bigger before transplantation and therefore become more
resilient to DTx toxicity. Four to 5 weeks later, 104 MECs from Lgr5-DTR:GFP
or WT littermates were contralaterally transplanted into precleared fat pads in
Matrigel/minimal medium plus 2.5 nM FGF2, 1:1 (Ewald et al., 2008) containing
1 mg/ml DTx (Sigma-Aldrich), or no DTx in external controls, to achieve imme-
diate but local Lgr5+ cell depletion. After 6 days,micewere injected intraperito-
neally (i.p.) with 50 ng/g body weight (BW) DTx, three times/week for 1.5 weeks
to maintain Lgr5+ cell depletion throughout the experiment. Mammary tissue
was collected 3 weeks posttransplantation, which is sufficient time to yield
mammary outgrowths. Due to possible DTx toxicity at the concentration of
50 ng/g BW, which allows full Lgr5+ depletion in the mammary, the treatment
regimen above could not beprolonged further to allowoutgrowths to fully prog-
ress, so the internal controls of outgrowths from WT cells, which are also sub-
jected to DTx, serve as a reference to the Lgr5-DTR:GFP outgrowths. The
external control group was i.p. injected with PBS under a similar regimen.
In a separate set of experiments, 4.5-week-old Lgr5-DTR or WT littermates
were injected i.p. with 50 ng/g BW DTx, three times per week for 1.5 weeks.
Inguinal MGs were retrieved, carmine stained, and the ductal-invaded area
was calculated. Calculation was done using ImageJ software—the ductal
area calculated is demarcated (the lymph node is the point of reference for
ductal invasion). Additionally, TEBs were manually counted directly from MG
wholemounts. Due to the possible effect of DTx depletion on additional organs
in Lgr5-DTR:GFP mice and DTx toxicity, these experiments could not be
prolonged beyond the current endpoint.
In Vivo Tamoxifen Induction
Four-week-old Lgr5-EGFP-IRES-creERT2/Rosa-Tomato female mice were
i.p. injected with 5 mg of Tamoxifen (Sigma-Aldrich) diluted in sunflower oil
(Sigma-Aldrich) every other day for a total of 3 days (15 mg total), as indicated
in Van Keymeulen et al. (2011). MGswere collected at 5, 6, and 7weeks of age,
and Cre induction was assessed by whole-mount fluorescence while epithelial
outgrowths were visualized by carmine staining.
For further details, see the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and two tables and can be found with this article online at http://dx.
doi.org/10.1016/j.celrep.2012.12.017.
LICENSING INFORMATION
This is an open-access article distributed under the terms of the Creative
Commons Attribution-NonCommercial-No Derivative Works License, which
permits non-commercial use, distribution, and reproduction in any medium,
provided the original author and source are credited.
ACKNOWLEDGMENTS
We thank Dr. Nirav Bhakta for help with the single-cell PCR analysis, Drs. Brian
Biehs and Hua Tian for initial help with the Lgr5-DTR:GFP breeding, Dr. Roland
Wedlich-Soeldner for providing the LifeAct-RFP mice, Michael Kissner for
assistance with flow cytometry, Ying Yu and Elena Atamaniuc for mice
husbandry and genotyping, and Joanne Dai for technical help. This work
was supported by grants from the National Cancer Institute, the National Insti-
tute of Environmental Health Sciences, and the National Institute of Dental and
Craniofacial Research (R01 CA057621 and U01 ES019458 to Z.W. and R01-
DE021420 to O.D.K.), by Department of Defense postdoctoral fellowships to
V.P. (W81XWH-11-01-0139) and to D.A.L. (W81XWH-11-1-0742), and the
Weizmann Institute of Science-National Postdoctoral Award Program for
Advancing Women in Science (to V.P.). F.d.S. is an employee of Genentech,
Inc., and owns shares at Roche.
Received: July 30, 2012
Revised: September 14, 2012
Accepted: December 26, 2012
Published: January 24, 2013
REFERENCES
Badders, N.M., Goel, S., Clark, R.J., Klos, K.S., Kim, S., Bafico, A., Lindvall, C.,
Williams, B.O., and Alexander, C.M. (2009). The Wnt receptor, Lrp5, is ex-
pressed by mouse mammary stem cells and is required to maintain the basal
lineage. PLoS One 4, e6594.
Barker, N., van Es, J.H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen,
M., Haegebarth, A., Korving, J., Begthel, H., Peters, P.J., and Clevers, H.
(2007). Identification of stem cells in small intestine and colon by marker
gene Lgr5. Nature 449, 1003–1007.
Barker, N., van Es, J.H., Jaks, V., Kasper, M., Snippert, H., Toftga˚rd, R., and
Clevers, H. (2008). Very long-term self-renewal of small intestine, colon, and
hair follicles from cycling Lgr5+ve stem cells. Cold Spring Harb. Symp. Quant.
Biol. 73, 351–356.
Barker, N., Ridgway, R.A., van Es, J.H., van de Wetering, M., Begthel, H., van
den Born, M., Danenberg, E., Clarke, A.R., Sansom, O.J., and Clevers, H.
(2009). Crypt stem cells as the cells-of-origin of intestinal cancer. Nature
457, 608–611.
Barker, N., Huch, M., Kujala, P., van de Wetering, M., Snippert, H.J., van Es,
J.H., Sato, T., Stange, D.E., Begthel, H., van den Born, M., et al. (2010).
Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived
gastric units in vitro. Cell Stem Cell 6, 25–36.Barker, N., Rookmaaker, M.B., Kujala, P., Ng, A., Leushacke, M., Snippert, H.,
van de Wetering, M., Tan, S., Van Es, J.H., Huch, M., et al. (2012). Lgr5(+ve)
stem/progenitor cells contribute to nephron formation during kidney develop-
ment. Cell Rep. 2, 540–552.
Boras-Granic, K., Chang, H., Grosschedl, R., and Hamel, P.A. (2006). Lef1 is
required for the transition ofWnt signaling frommesenchymal to epithelial cells
in the mouse embryonic mammary gland. Dev. Biol. 295, 219–231.
Brisken, C., Heineman, A., Chavarria, T., Elenbaas, B., Tan, J., Dey, S.K.,
McMahon, J.A., McMahon, A.P., andWeinberg, R.A. (2000). Essential function
of Wnt-4 in mammary gland development downstream of progesterone
signaling. Genes Dev. 14, 650–654.
Carmon, K.S., Gong, X., Lin, Q., Thomas, A., and Liu, Q. (2011). R-spondins
function as ligands of the orphan receptors LGR4 and LGR5 to regulate
Wnt/beta-catenin signaling. Proc. Natl. Acad. Sci. USA 108, 11452–11457.
Chadi, S., Buscara, L., Pechoux, C., Costa, J., Laubier, J., Chaboissier, M.C.,
Pailhoux, E., Vilotte, J.L., Chanat, E., and Le Provost, F. (2009). R-spondin1 is
required for normal epithelial morphogenesis during mammary gland develop-
ment. Biochem. Biophys. Res. Commun. 390, 1040–1043.
Chu, E.Y., Hens, J., Andl, T., Kairo, A., Yamaguchi, T.P., Brisken, C., Glick, A.,
Wysolmerski, J.J., and Millar, S.E. (2004). Canonical WNT signaling promotes
mammary placode development and is essential for initiation of mammary
gland morphogenesis. Development 131, 4819–4829.
de Lau, W., Barker, N., Low, T.Y., Koo, B.K., Li, V.S., Teunissen, H., Kujala, P.,
Haegebarth, A., Peters, P.J., van de Wetering, M., et al. (2011). Lgr5 homo-
logues associate withWnt receptors andmediate R-spondin signalling. Nature
476, 293–297.
Deome, K.B., Faulkin, L.J., Jr., Bern, H.A., and Blair, P.B. (1959). Development
of mammary tumors from hyperplastic alveolar nodules transplanted into
gland-free mammary fat pads of female C3H mice. Cancer Res. 19, 515–520.
de Visser, K.E., Ciampricotti, M., Michalak, E.M., Tan, D.W., Speksnijder, E.N.,
Hau, C.S., Clevers, H., Barker, N., and Jonkers, J. (2012). Developmental
stage-specific contribution of LGR5(+) cells to basal and luminal epithelial line-
ages in the postnatal mammary gland. J. Pathol. 228, 300–309.
Ewald, A.J., Brenot, A., Duong, M., Chan, B.S., andWerb, Z. (2008). Collective
epithelial migration and cell rearrangements drive mammary branching
morphogenesis. Dev. Cell 14, 570–581.
Gilman, A.G., Simon, M.I., Bourne, H.R., Harris, B.A., Long, R., Ross, E.M.,
Stull, J.T., Taussig, R., Bourne, H.R., Arkin, A.P., et al.; Participating investiga-
tors and scientists of the Alliance for Cellular Signaling. (2002). Overview of the
Alliance for Cellular Signaling. Nature 420, 703–706.
Gong, X., Carmon, K.S., Lin, Q., Thomas, A., Yi, J., and Liu, Q. (2012). LGR6 is
a high affinity receptor of R-spondins and potentially functions as a tumor
suppressor. PLoS One 7, e37137.
Keller, P.J., Arendt, L.M., and Kuperwasser, C. (2011). Stem cell maintenance
of the mammary gland: it takes two. Cell Stem Cell 9, 496–497.
Kordon, E.C., and Smith, G.H. (1998). An entire functional mammary gland
may comprise the progeny from a single cell. Development 125, 1921–1930.
Lindvall, C., Evans, N.C., Zylstra, C.R., Li, Y., Alexander, C.M., and Williams,
B.O. (2006). The Wnt signaling receptor Lrp5 is required for mammary ductal
stem cell activity and Wnt1-induced tumorigenesis. J. Biol. Chem. 281,
35081–35087.
Lindvall, C., Zylstra, C.R., Evans, N., West, R.A., Dykema, K., Furge, K.A., and
Williams, B.O. (2009). The Wnt co-receptor Lrp6 is required for normal mouse
mammary gland development. PLoS One 4, e5813.
Long, J.Z., Lackan, C.S., and Hadjantonakis, A.K. (2005). Genetic and spec-
trally distinct in vivo imaging: embryonic stem cells and mice with widespread
expression of a monomeric red fluorescent protein. BMC Biotechnol. 5, 20.
Madisen, L., Zwingman, T.A., Sunkin, S.M., Oh, S.W., Zariwala, H.A., Gu, H.,
Ng, L.L., Palmiter, R.D., Hawrylycz, M.J., Jones, A.R., et al. (2010). A robust
and high-throughput Cre reporting and characterization system for the whole
mouse brain. Nat. Neurosci. 13, 133–140.
McClanahan, T., Koseoglu, S., Smith, K., Grein, J., Gustafson, E., Black, S.,
Kirschmeier, P., and Samatar, A.A. (2006). Identification of overexpression ofCell Reports 3, 70–78, January 31, 2013 ª2013 The Authors 77
orphan G protein-coupled receptor GPR49 in human colon and ovarian
primary tumors. Cancer Biol. Ther. 5, 419–426.
Nusse, R., and Varmus, H.E. (1982). Many tumors induced by the mouse
mammary tumor virus contain a provirus integrated in the same region of the
host genome. Cell 31, 99–109.
Oskarsson, T., Acharyya, S., Zhang, X.H., Vanharanta, S., Tavazoie, S.F.,
Morris, P.G., Downey, R.J., Manova-Todorova, K., Brogi, E., and Massague´,
J. (2011). Breast cancer cells produce tenascin C as a metastatic niche
component to colonize the lungs. Nat. Med. 17, 867–874.
Oyama, K., Mohri, Y., Sone, M., Nawa, A., and Nishimori, K. (2011). Conditional
knockout of Lgr4 leads to impaired ductal elongation and branching morpho-
genesis in mouse mammary glands. Sex Dev. 5, 205–212.
Riedl, J., Flynn, K.C., Raducanu, A., Ga¨rtner, F., Beck, G., Bo¨sl, M., Bradke, F.,
Massberg, S., Aszodi, A., Sixt, M., and Wedlich-So¨ldner, R. (2010). Lifeact
mice for studying F-actin dynamics. Nat. Methods 7, 168–169.
Roelink, H., Wagenaar, E., Lopes da Silva, S., and Nusse, R. (1990). Wnt-3,
a gene activated by proviral insertion in mouse mammary tumors, is homolo-
gous to int-1/Wnt-1 and is normally expressed in mouse embryos and adult
brain. Proc. Natl. Acad. Sci. USA 87, 4519–4523.
Schepers, A.G., Snippert, H.J., Stange, D.E., van den Born, M., van Es, J.H.,
van de Wetering, M., and Clevers, H. (2012). Lineage tracing reveals Lgr5+
stem cell activity in mouse intestinal adenomas. Science 337, 730–735.
Shackleton, M., Vaillant, F., Simpson, K.J., Stingl, J., Smyth, G.K., Asselin-
Labat, M.L., Wu, L., Lindeman, G.J., and Visvader, J.E. (2006). Generation of
a functional mammary gland from a single stem cell. Nature 439, 84–88.
Sleeman, K.E., Kendrick, H., Robertson, D., Isacke, C.M., Ashworth, A., and
Smalley, M.J. (2007). Dissociation of estrogen receptor expression and in vivo
stem cell activity in the mammary gland. J. Cell Biol. 176, 19–26.
Spike, B.T., Engle, D.D., Lin, J.C., Cheung, S.K., La, J., and Wahl, G.M. (2012).
A mammary stem cell population identified and characterized in late
embryogenesis reveals similarities to human breast cancer. Cell Stem Cell
10, 183–197.78 Cell Reports 3, 70–78, January 31, 2013 ª2013 The AuthorsStingl, J., and Caldas, C. (2007). Molecular heterogeneity of breast carcinomas
and the cancer stem cell hypothesis. Nat. Rev. Cancer 7, 791–799.
Stingl, J., Eirew, P., Ricketson, I., Shackleton, M., Vaillant, F., Choi, D., Li, H.I.,
and Eaves, C.J. (2006). Purification and unique properties of mammary epithe-
lial stem cells. Nature 439, 993–997.
Tian, H., Biehs, B., Warming, S., Leong, K.G., Rangell, L., Klein, O.D., and de
Sauvage, F.J. (2011). A reserve stem cell population in small intestine renders
Lgr5-positive cells dispensable. Nature 478, 255–259.
van Amerongen, R., Bowman, A.N., and Nusse, R. (2012). Developmental
stage and time dictate the fate of Wnt/b-catenin-responsive stem cells in the
mammary gland. Cell Stem Cell 11, 387–400.
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone,
A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.P., et al. (2002). The
beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colo-
rectal cancer cells. Cell 111, 241–250.
Van Keymeulen, A., Rocha, A.S., Ousset, M., Beck, B., Bouvencourt, G., Rock,
J., Sharma, N., Dekoninck, S., and Blanpain, C. (2011). Distinct stem cells
contribute to mammary gland development and maintenance. Nature 479,
189–193.
Visvader, J.E., and Lindeman, G.J. (2006). Mammary stem cells and mammo-
poiesis. Cancer Res. 66, 9798–9801.
Welm, B., Behbod, F., Goodell, M.A., and Rosen, J.M. (2003). Isolation
and characterization of functional mammary gland stem cells. Cell Prolif.
36(Suppl 1), 17–32.
Woodward, W.A., Chen, M.S., Behbod, F., and Rosen, J.M. (2005). On
mammary stem cells. J. Cell Sci. 118, 3585–3594.
Yamamoto, Y., Sakamoto, M., Fujii, G., Tsuiji, H., Kenetaka, K., Asaka, M., and
Hirohashi, S. (2003). Overexpression of orphan G-protein-coupled receptor,
Gpr49, in human hepatocellular carcinomas with beta-catenin mutations.
Hepatology 37, 528–533.
Zeng, Y.A., and Nusse, R. (2010). Wnt proteins are self-renewal factors for
mammary stem cells and promote their long-term expansion in culture. Cell
Stem Cell 6, 568–577.
